Literature DB >> 23876379

A novel splicing mutation in the SEDL gene causes spondyloepiphyseal dysplasia tarda in a large Chinese pedigree.

Hui Wang1, Weiqing Wu, Zhiyong Xu, Jiansheng Xie.   

Abstract

The X-linked form of spondyloepiphyseal dysplasia tarda (SEDT, OMIM# 313400) is a rare osteochondrodysplasia caused by mutations in the SEDL (TRAPPC2, OMIM# 300202) gene. It is clinically characterized by disproportionate short stature, barrel-shaped chests and early development of degenerative joint disease. We report here a novel mutation in the intron 3 splice-donor site (c. 93+5G>C) segregated in an X-link pattern in a large Chinese family with SEDT. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis revealed that the mutation causes an aberrant splicing of exon 3, resulting in the elimination of 31 codons in the exon and a considerable loss function of the SEDL protein. This mutation was not detected in the 100 healthy controls. This novel mutation adds to the spectrum of previously-identified disease-causing mutations. Pre-symptomatic molecular diagnosis and prenatal diagnosis of the pregnant carriers could be helpful to families with SEDT.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  SEDL gene; Splicing mechanism; Splicing mutation; Spondyloepiphyseal dysplasia tarda (SEDT); X-linked

Mesh:

Substances:

Year:  2013        PMID: 23876379     DOI: 10.1016/j.cca.2013.07.002

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  A novel deletion variant in TRAPPC2 causes spondyloepiphyseal dysplasia tarda in a five-generation Chinese family.

Authors:  Cai Zhang; Caiqi Du; Juan Ye; Feng Ye; Renfa Wang; Xiaoping Luo; Yan Liang
Journal:  BMC Med Genet       Date:  2020-05-29       Impact factor: 2.103

2.  Clinical Diagnosis of X-Linked Spondyloepiphyseal Dysplasia Tarda and a Novel Missense Mutation in the Sedlin Gene (SEDL).

Authors:  Lei Kong; Dongxu Wang; Shanshan Li; Chengsheng Zhang; Xiuyun Jiang; Qingbo Guan; Zhenlin Zhang; Fei Jing; Jin Xu
Journal:  Int J Endocrinol       Date:  2018-12-10       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.